Generate a tailored SOP for Dr. Emil Kofod Olsen. Improve your application with a focused, well-structured draft.
Emil Kofod-Olsen is an Associate Professor at Aalborg University specializing in Medical Microbiology and Immunology. His research centers on cancer immunotherapy, particularly focusing on pre-clinical mouse tumor models utilizing dendritic cell therapy. His studies are divided into arms that explore STING-targeted therapies and related therapeutic cancer vaccines. The research aims to leverage cholesterol-interfering drugs to prime the STING-pathway, enhancing susceptibility to immunotherapy. Additionally, Kofod-Olsen investigates caspase inhibition for STING-pathway activation. He has developed a small recombinant protein vaccine which matures dendritic cells, leading to the activation of tumor-specific T cells and engendering the potential for effective antigen presentation in conjunction with T cell activation during immune checkpoint inhibitor treatments. He actively contributes to teaching through lectures, case sessions, and laboratory courses in both Immunology and Microbiology, alongside supervising PhD students and serving on various academic committees.
Aalborg University • Gistrup, Denmark
Conducts research and teaches in Medical Microbiology and Immunology.
Requirements apply generally to Master's programs across departments including Sociology, Business, and Engineering at Aalborg University.